
Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09)
2024; Lippincott Williams & Wilkins; Volume: 42; Issue: 23 Linguagem: Inglês
10.1200/jco.23.02082
ISSN1527-7755
AutoresNizar M. Tannir, Maria Nirvana Formiga, Konstantin Penkov, Nikolay Kislov, Aleksandr Vasiliev, Nils Gunnar Skare, Walter Hong, Stanley Dai, Lily Tang, Anila Qureshi, Jonathan Zalevsky, Mary Tagliaferri, Daniel J. George, Neeraj Agarwal, Sumanta K. Pal, Omkar Marathe, Brendan D. Curti, Arif Hussain, Mehmet Asım Bilen, Sumanta K. Pal, Nizar M. Tannir, Edward Uchio, Seresh Nair, Richard Zuniga, William R. Clark, Neeraj Agarwal, William Tester, Emily Franks, Kamal Patel, Pedro Barata, Janaki Sharma, Saba Radhi, Monika Joshi, Francis Parnis, Howard Gurney, Robert Zielinski, Alexander Guminski, David Campbell, Simon Fu, Alexandr Vasiliev, Evgeniy Kopyltsov, Konstantin Penkov, Oleg Gladkov, David S. Perlin, Dmitry Nosov, Vladimir Kheifets, Igor Lifirenko, Sergey Varlamov, Nikolay Kislov, Oleg Karyakin, E. K. Zhiltsova, Natalia Fadeeva, Susana Kahl, Rubén Dario Kowalyszyn, N. Pilnik, Valeria Agostinetti Amuchastegui, Andrea Pastor, Rocío Vázquez, Diego Kaen, Mario Alfredo Brown Arnold, Felipe Salvador Palazzo, Gustavo Jarchum, Yanina Pflüger, Jorge Salinas, Juan Pablo Re, Sérgio Jobim Azevedo, Andre Poisi Fay, Celio Kussumoto, Roberto Odebrecht Rocha, Ubirajara Ferreira, Jeferson Jose da Fonseca Vinholes, Gustavo Girotto, Victor Marcondes Lopes dos Santos, Maria Nirvana Formiga, Manuela Zereu, Rita de Cassia Costamilan, Daniel D’Almeida Preto, João Paulo Holanda Soares, Nils Gunnar Skare, Ariel Galapo Kann, Rodrigo Cunha Guimaraes, Suelen Patrícia dos Santos Martins, Alan A. Azambuja, Jose Alberto Lopes Nogueira, Leandro Brust, J. G. M. Segalla, Maite de Liz Vassen Schurmann, Fábio Franke, Silvio Correia Sales, Daniel de Castro Monteiro, Gisele Marinho dos Santos, Augusto César de Andrade Mota, Jose Luis Martinez Lira, Eduardo Téllez Bernal, Denisse Anorve Bailon, I. Alvarez, Francisco Soto, Carmen Laura Acevedo Zanabria, Alejandro Figueroa Torrejon, Jose David Zorrilla Silvera, Renzo Mauricio Salas Rojas, Sergio Panay, Alejandro Andres Acevedo Gaete, Mario Alberto Gorena Palominos, Pamela Victoria Salman Boghikian, Eugenia de las Nieves Loredo Fort, Eric Armando Orellana Ulunque, Valentina Isabel Hornig Epple, Sergio Fabian Elqueta Pinochet, Thomas Soh I. Peng, Ng Quan Sing, Pamela Crilley, Muhammad Owais Abdul Ghani,
Tópico(s)CAR-T cell therapy research
ResumoBempegaldesleukin (BEMPEG) is a pegylated interleukin (IL)-2 cytokine prodrug engineered to provide controlled and sustained activation of the clinically validated IL-2 pathway, with the goal of preferentially activating and expanding effector CD8
Referência(s)